REM Sleep Behavior Disorder: Clinical Trials

101 trials for REM Sleep Behavior Disorder, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

27 recruiting, 23 unknown, 19 completed, 13 active not recruiting. 29 Not applicable, 15 Phase 2, 6 Phase 4, 2 Phase 1, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable29Recruiting 13, Completed 5, Unknown 4, Terminated 3, Not yet recruiting 2, Active not recruiting 1, Suspended 1
Phase 215Active not recruiting 7, Completed 3, Withdrawn 2, Recruiting 1, Terminated 1, Unknown 1
Phase 46Completed 2, Enrolling by invitation 2, Recruiting 1, Unknown 1
Phase 12Completed 1, Not yet recruiting 1
Phase 32Withdrawn 2
Early Phase 11Terminated 1

Follow REM Sleep Behavior Disorder: new trials by email Literature Review of REM Sleep Behavior Disorder trials Research Report on REM Sleep Behavior Disorder

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Artificial Intelligence-based Parkinson's Disease Risk Assessment (AI-PRA) Study
Smartwatch and phone app - Parkinson Disease (PD), REM Sleep Behavior Disorder (iRBD)
Not yet recruitingQueen Mary University of London602026-10-012026-10-02
An Exploratory Study of the Potential for Rational Immune System Manipulation to Prevent Emergence of Synucleinopathy Manifestations in Persons With REM Sleep Behavior Disorder (RBD)
Adalimumab, Placebo - REM Sleep Behavior Disorder
Phase 2RecruitingYale University1082026-08-172026-10-08
INSIGHT: Insomnia, Nightmares, and Sympathetic Hyperactivity Intervention
NightWare smartwatch configured to detect physiological signs of sympathetic activation during sleep, such as heart-rate spikes and movement patterns., Sham (No Treatment) - Nightmare, Insomnia
Not applicableNot yet recruitingUniformed Services University of the Health Sciences1802026-06-012026-04-28
Understanding Alpha-Synuclein Spread in Parkinson's Disease Through Blood Biomarkers and Neuroimaging
brain imaging, blood draw, Skin biopsy - Parkinson's Disease (PD), GBA1 Parkinson Disease
Not applicableNot yet recruitingUniversity of Pavia1602026-05-112026-05-01
PET-MRI of Reward System in Parkinson's Disease With RBD
PET-MRI (Positron Emission Tomography - Magnetic Resonance Imaging). - Parkinson's Disease (PD)
Not applicableRecruitingUniversity Hospital, Clermont-Ferrand442026-05-072026-07-08
L-THEANINE AND MEDITERRANEAN DIET ON RBD, GI FUNCTION, AND INFLAMMATION IN PARKINSON'S DISEASE
Dietary Supplement, Control group (placebo) - Parkinson Disease (PD)
Not applicableRecruitingMedipol University522026-05-022026-07-06
Pain Assessment in Patients With Idiopathic Rapid Eye Movement (REM) Sleep Behaviour Disorder
Thermo test pain, Pain questionnaires, No motors symptoms evaluations - REM Sleep Behavior Disorder (iRBD), Narcolepsy Type 1
Not applicableRecruitingUniversity Hospital, Toulouse242026-02-242026-05-01
Ultra-High Resolution PET in Aging, Neurodegeneration and Psychotic Disorders
UHR PET/CT scan of the brain with ¹⁸F-FDG, UHR PET/CT scan of the brain with ¹⁸F-PE2I, UHR PET/CT scan of the brain with ¹⁸F-SynVesT-1 - Alzheimer Dementia (AD), ALS - Amyotrophic Lateral Sclerosis
Not applicableRecruitingUniversitaire Ziekenhuizen KU Leuven3002026-02-132026-04-03
A Comprehensive, Multimodal Characterization of Prodromal PD in Subjects With RBD
REM Sleep Behavior Disorder, Synucleinopathies
RecruitingDanish Research Centre for Magnetic Resonance1002026-02-012026-08-27
Role of Slow Waves in the Progression of Neurodegeneration in Isolated REM Sleep Behavior Disorder
Tosoo Axora - Parkinson Disease, REM Sleep Behavior Disorder (iRBD)
Not applicableRecruitingUniversity of Zurich802026-01-152026-02-17
Ginger-PD: Ginger as a Modifier of Ghrelin Levels and Gut Function in Parkinson's Disease
Ginger - REM Sleep Behavior Disorder, Parkinson s Disease
Not applicableRecruitingCambridge University Hospitals NHS Foundation Trust722025-12-172026-10-21
Development and Online Evaluation of an Online Course for Parasomnias
Parasomnia Education, Sleep Hygiene Control - Sleep Terror, Sleepwalking
Not applicableRecruitingUniversity of Manitoba202025-11-142026-01-23
The Role of METhanogens in the PROgression Of Parkinson's Disease and Related Neurological Conditions
Probiotic Supplementation with L. reuteri - PARKINSON DISEASE (Disorder), Parkinson
Not applicableRecruitingUniversity of Cambridge2152025-11-012026-08-25
Evaluating the Efficacy and Safety of PROSOMNIA Sleep Therapy™ in Patients With Sleep Deprivation and Chronic Insomnia
PROSOMNIA Sleep Therapy™ (PSTx), Anesthesia-Induced Sleep Therapy, Diprivan (propofol), Astra-Zeneca - Chronic Insomnia, Sleep Deprivation
Phase 1Not yet recruitingNyree Penn1002025-11-012025-05-28
Unmet Needs Among Patients With Isolated REM Sleep Behavior Disorder (iRBD) and Their Significant Others
REM Sleep Behavior Disorder, Isolated REM Sleep Behavior Disorder
RecruitingUniversita di Verona1502025-05-062026-03-27
Study of Sleep Disorders in Prodromal and Definite Parkinsons Disease
Polysomnography - Parkinson Disease, REM Sleep Behavior Disorder (iRBD)
Not applicableRecruitingAssistance Publique - Hôpitaux de Paris4572025-03-182026-03-06
The Impact of Light, Electrical, and Magnetic Neuroregulation Interventions on Sleep-wake Disorders
Transcranial Magnetic Stimulation - Insomnia Chronic, Narcolepsy
Not applicableRecruitingSecond Affiliated Hospital of Soochow University202025-02-012025-02-14
Quantification of Phosphorylated Alpha-synuclein in Cutaneous Biopsies as a Prospective Biomarker in Parkinson's Disease
REM Behavior Disorder, Parkinson Disease
Active not recruitingCND Life Sciences1002024-12-172026-10-20
[18F] - FD17 PET Imaging of α-synuclein: A Clinical Study in α-synucleinopathy Patients
PET - α-synucleinopathy, Parkinson's Disease (PD)
CompletedRuijin Hospital552024-12-142026-03-05
IMPACT 360 for Parkinson's Disease
Exercise, Meditation, Diet - Parkinson's Disease (PD), REM Sleep Behavior Disorder
Phase 2Active not recruitingUniversity of British Columbia602024-10-282026-06-25

Showing 20 of 101. Sign in to see all of them.

Narrower conditions

Parkinson Disease (54)  ·  Lewy Body Disease (14)  ·  Nerve Degeneration (9)  ·  Synucleinopathies (9)  ·  Multiple System Atrophy (8)  ·  Parkinsonian Disorders (7)  ·  Dementia (5)  ·  Cognitive Dysfunction (4)  ·  Narcolepsy (4)  ·  Neurodegenerative Diseases (4)  ·  Parkinson Disease, Secondary (4)  ·  Sleep Initiation and Maintenance Disorders (4)  ·  Sleep Wake Disorders (4)  ·  Alzheimer Disease (3)

Broader conditions

Mental Disorders (100)  ·  Nervous System Diseases (100)  ·  Parasomnias (99)  ·  REM Sleep Parasomnias (99)  ·  Sleep Wake Disorders (97)  ·  Central Nervous System Diseases (65)  ·  Brain Diseases (64)  ·  Basal Ganglia Diseases (61)  ·  Movement Disorders (61)  ·  Neurodegenerative Diseases (58)  ·  Parkinsonian Disorders (54)  ·  Synucleinopathies (51)  ·  Pathological Conditions, Signs and Symptoms (27)  ·  Neurocognitive Disorders (18)  ·  Pathologic Processes (15)

Interventions

Clonazepam (3)  ·  Melatonin (3)  ·  Blood Specimen Collection (2)  ·  Carvedilol (2)  ·  Magnetic Resonance Imaging (2)  ·  Polysomnography (2)  ·  idebenone (2)  ·  ioflupane (2)  ·  nelotanserin (2)  ·  ramelteon (2)  ·  (methyl-(11)C)N-acetyl-N-(2-methoxybenzyl)-2-phenoxy-5-pyridinamine (1)  ·  3-Iodobenzylguanidine (1)  ·  Adalimumab (1)  ·  Biological Factors (1)  ·  Cognitive Behavioral Therapy (1)

Sponsors

Chinese University of Hong Kong (11)  ·  University Hospital, Clermont-Ferrand (6)  ·  Seoul National University Hospital (5)  ·  Cedars-Sinai Medical Center (3)  ·  Mayo Clinic (3)  ·  Ruijin Hospital (3)  ·  Axovant Sciences Ltd. (2)  ·  CND Life Sciences (2)  ·  IRCCS San Raffaele (2)  ·  NYU Langone Health (2)  ·  Second Affiliated Hospital, Zhejiang University, School of Medicine (2)  ·  University Hospital, Toulouse (2)  ·  University of Minnesota (2)  ·  Washington University School of Medicine (2)  ·  Yale University (2)

Countries

United States (35)  ·  France (15)  ·  Hong Kong (11)  ·  United Kingdom (9)  ·  Canada (7)  ·  China (7)  ·  South Korea (7)  ·  Italy (6)  ·  Germany (3)  ·  Spain (3)  ·  Denmark (2)  ·  Switzerland (2)  ·  Argentina (1)  ·  Australia (1)  ·  Austria (1)

Top investigators

Jihui Zhang, PhD (4)  ·  Yun Kwok Wing, MBChB (4)  ·  Yun Kwok Wing, Professor (4)  ·  Bradley Boeve, MD (3)  ·  Baorong Zhang, MD (2)  ·  Horacio C Kaufmann, MD (2)  ·  Ilise Lombardo, MD (2)  ·  Michele Tagliati, MD, FAAN (2)  ·  Shirley Xin Li, PhD (2)  ·  Todd Levine (2)  ·  Vincent Chung Tong Mok, MBChB (2)  ·  Aleksandar Videnovic, M.D. (1)  ·  Alexander Shtilbans, MD (1)  ·  Andreas Luft, Prof. Dr. med. (1)  ·  Artur F Schuh-Schumacher, Dr. (1)

Results publications

PMID 10214756, PMID 10406987, PMID 10527042, PMID 10853813, PMID 10979878, PMID 11076832, PMID 11400186, PMID 11724917, PMID 12498954, PMID 12904089, PMID 15175402, PMID 15345186, PMID 15645531, PMID 15779234, PMID 16025231, PMID 16442563, PMID 16715205, PMID 16837857, PMID 17190953, PMID 18079166, PMID 18349024, PMID 19018276, PMID 20146689, PMID 20188504, PMID 20846908, PMID 20887968, PMID 20976736, PMID 21045744, PMID 21421334, PMID 21538520, PMID 21571570, PMID 21700495, PMID 21802993, PMID 22321865, PMID 22483040, PMID 22508280, PMID 23024438, PMID 23160999, PMID 23266935, PMID 23329524, PMID 23347909, PMID 23562390, PMID 23647842, PMID 23970363, PMID 24332912, PMID 24637128, PMID 25483722, PMID 25589269, PMID 25666029, PMID 25681454

NIH funding

2023 (1), R01AG095016 (1), R01NS095562 (1), R34AG056639 (1), U19AG071754 (1)